Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. - Wikidata - wikimedia - TriplyDB

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.

http://www.wikidata.org/entity/Q44544539

about

Hepatic radiation toxicity: avoidance and amelioration Incorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapy Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities.Stem cell therapies for the treatment of radiation-induced normal tissue side effects.Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Radiotherapy for hepatocellular carcinoma: systematic review of radiobiology and modeling projections indicate reconsideration of its use.Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma.Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy Radiation-associated liver injury.Integrative Metabolic Signatures for Hepatic Radiation Injury.Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.Factors associated with hepatic dysfunction in hepatitis B-positive patients with postgastrectomy adenocarcinoma.RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma Hedgehog signaling and radiation induced liver injury: a delicate balance.Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma.Identification of Biologically Effective Dose-Volumetric Parameters That Predict Radiation-Induced Hepatic Toxicity in Patients Treated With Helical Tomotherapy for Unresectable Locally Advanced Hepatocellular Carcinoma.High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities Liver function after irradiation based on computed tomographic portal vein perfusion imaging Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters Challenge and hope in radiotherapy of hepatocellular carcinoma Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results.Biomarker studies on radiotherapy to hepatocellular carcinoma.Role of external beam radiation therapy in management of hepatocellular carcinoma.Radiation-induced liver disease: current understanding and future perspectives A Review of Non-operative Treatments for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus.Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve.The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma.Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry.Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma.Strategies for prediction and mitigation of radiation-induced liver toxicity.Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.Stereotactic body radiation therapy for liver metastases and primary hepatocellular carcinoma: normal tissue tolerances and toxicity.

P2860

Q27023687-D3F1F063-DCDC-4239-AFEC-EF04094E1277 Q27030865-C5DAD04B-B1E9-48C9-A07E-404A3A3D44B5 Q33257944-666F6EC4-FE39-43E9-8CFB-5D6BBE19F97B Q33593108-1FEEA7DC-D70F-4B18-8971-3A58E779B893 Q33699349-0F6E8BC4-708A-4BD4-8908-8C1910CA94D6 Q33746887-BD85998C-0122-4DE2-9ADD-2B669735A906 Q33768112-9D0E3ABD-DEEC-4E4D-9ECD-33E7B8D54BA9 Q33818431-DB0FE5C9-CBB2-4135-B5DB-A1C238C541E8 Q34615726-9D116C77-307F-413D-AEEB-85687DE90DE3 Q35051831-F4A4B567-9B48-4C28-9E11-4E429BEAD1A5 Q35111353-488B5149-FD97-4A82-B4C4-059F5EBE9A48 Q35297759-3C38C192-A287-44BC-B24B-F63D9FF0B421 Q35654209-B0D01213-D680-48C7-80C4-758ED364ED81 Q36074220-A45FA0F8-882C-4E76-AC3E-AF841A56D082 Q36225933-6CAE984D-4B01-48D8-8350-AF0B3A1820AB Q36326035-864703F0-8751-4DC3-9082-632B1ACDCF5D Q36545343-205D71C9-F7BC-42CB-9E20-C967123C2A04 Q36570322-C7DB8B08-68B0-4D0B-9E42-B25143A030FF Q36811589-F113E294-D2C7-47F2-B6B9-C8D11B036D67 Q36955776-01CE58F4-0676-4FB9-BCFE-58A9F49905C5 Q37013991-73C53806-3101-49DF-BDDF-421D63A67839 Q37059598-272A1D08-CFEE-46FC-A518-166CA5F701FD Q37176354-A4236699-699B-40D4-848B-64EF957EF855 Q37269624-913B7DAF-B633-4673-8037-0A57E2FCE2A0 Q37272492-BC6E6688-255C-4F5F-9E43-6FCA29E9FC2F Q37277060-A966798B-7FAE-4ADA-88E2-62619F31DD01 Q37400936-F6537E62-42CD-49E7-9ED4-91F4B0296BAD Q37487162-6C4705A6-089D-43BA-BC78-5B0DB1B3D9B2 Q38083433-D5791E6C-47B8-43EE-8B82-9F2D944B6558 Q38371619-6184B7DE-596C-407A-9435-1817140DF9B1 Q38654063-14955039-A1F4-47DD-92CF-757F69664A80 Q38665389-BA44C397-D3B7-4BB9-904D-4C1622A9979B Q38677020-8BB8FCF6-6363-4B06-BA6D-27688B200BB2 Q43865857-71D3488E-0B53-4724-8078-258BE9499E08 Q43897398-5D6C98CA-1CA2-4A67-8380-9CA878ADA5A1 Q47665576-B81E6256-C2C0-4FA6-B7E1-426F503ACEC4 Q49896456-94DB9C64-1FF6-4CF6-9C9A-7379645BAF23 Q50061872-F5940D07-4D06-4C44-979C-3F1B0ED090B3 Q51778319-3AD16316-5466-4218-AC5A-B21C965D8AD6 Q53118337-3C371B4E-02D5-416A-ACF0-3976B9AA127D

P2860

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.

http://www.wikidata.org/entity/Q44544539

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Biologic susceptibility of hep ...... diation-induced liver disease.

@en

Biologic susceptibility of hep ...... diation-induced liver disease.

@nl

type

label

Biologic susceptibility of hep ...... diation-induced liver disease.

@en

Biologic susceptibility of hep ...... diation-induced liver disease.

@nl

prefLabel

Biologic susceptibility of hep ...... diation-induced liver disease.

@en

Biologic susceptibility of hep ...... diation-induced liver disease.

@nl

P1433

Q44544539-69ECB16B-C0BD-46AC-8D01-FE22557830BB

P1476

Q44544539-A4EAC5B3-C2BE-4CEB-8519-82A06A65AEE8

P2093

Q44544539-07D1A3BB-9552-43CE-80E2-58D6A6E8DA1B

Q44544539-13FFA866-1B37-4357-9BC9-6DAB26FDBAED

Q44544539-510548CE-E139-4B93-A40C-984A56FC4713

Q44544539-53FDB3A3-102C-4732-B61D-54B50CCDD7D8

Q44544539-5B8B0284-F054-461A-80BE-C6D26A66F05D

Q44544539-5C0504F9-C1B2-4580-9DC7-BD431BEFED5A

Q44544539-96154FB2-84B7-4D2C-91C9-75A0A8288E5D

Q44544539-AF7199BE-075C-43E4-BADC-65BC188AFE74

P304

Q44544539-CCB3296F-6B02-4DC6-BD8F-D297DF6E0ED1

P31

Q44544539-A36A7149-266D-47A7-9369-27E6A02762EE

P356

Q44544539-D6A71ECA-50B1-4588-BCE7-053B7FA4F70A

P407

Q44544539-8A34CF10-30CE-4520-A9DA-7CAED11C642F

P433

Q44544539-4AFB9B6C-A891-4681-8FA6-A19B1C3E6DFA

P478

Q44544539-877F89CD-4E65-4011-8FA0-6BCCF0BC43BD

P577

Q44544539-0FD9AADD-68B8-493D-93DC-54342EF97B30

P5875

Q44544539-8A74EC8A-3046-4776-AC0D-B7E726439B79

P698

Q44544539-05908EAF-DD15-44F3-AB08-C51D870BCBB9

P921

Q44544539-18DFCB33-FC2B-4F16-8664-D04222D0B24E

P356

J.IJROBP.2004.05.048

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Biologic susceptibility of hep ...... diation-induced liver disease.

@en

P2093

Gwo-Jen Jan

http://www.w3.org/2001/XMLSchema#string

Hua-Shan Liu

http://www.w3.org/2001/XMLSchema#string

James Jer-Min Jian

http://www.w3.org/2001/XMLSchema#string

Jason Chia-Hsien Cheng

http://www.w3.org/2001/XMLSchema#string

Jian-Kuen Wu

http://www.w3.org/2001/XMLSchema#string

Juei-Low Sung

http://www.w3.org/2001/XMLSchema#string

Patricia Chiao-Tzu Lee

http://www.w3.org/2001/XMLSchema#string

Yu-Mong Lin

http://www.w3.org/2001/XMLSchema#string

P304

1502-1509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2004.05.048

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8138211

http://www.w3.org/2001/XMLSchema#string

P698

15590181

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy